Product overview

Name Cystamine dihydrochloride
Description Transglutaminase inhibitor
Write Your Own Review
You're reviewing:Cystamine dihydrochloride
Rate this item:

Biological Data

Biological description Transglutaminase inhibitor. Shows neuroprotective actions and acts as an antioxidant. Shows actions against Huntington's disease.

Solubility & Handling

Solubility overview Soluble in water (100mM) or DMSO (100mM)
Storage instructions room temperature (desiccate)
Storage of solutions Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Chemical name 2,2'-Diaminodiethyl disulfide dihydrochloride
Molecular Weight 225.2
Chemical structure Cystamine dihydrochloride  [56-17-7] Chemical Structure
Molecular Formula C4H12N2S2.2HCl
CAS Number 56-17-7
PubChem identifier 5941
SMILES NCCSSCCN.Cl.Cl
InChiKey YUFRRMZSSPQMOS-UHFFFAOYSA-N

References for Cystamine dihydrochloride

References are publications that support the biological activity of the product
  • Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.

    Ribeiro M et al (2013) Toxicol Sci 136(2) : 487-99.
  • Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

    Borrell-Pagès M et al (2006) J Clin Invest 116(5) : 1410-24.
  • Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.

    Mao Z et al (2006) Eur J Neurosci 23(7) : 1701-10.
  • Therapeutic effects of cystamine in a murine model of Huntington's disease.

    Dedeoglu A et al (2002) J Neurosci 22(20) : 8942-50.

4 Item(s)